Bausch + Lomb Launches the #LUMIFYEyeDance Challenge on TikTok
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Bausch & Lomb Corp. (BLCO) Not Impacted by Xifaxan Loss, Buy Weakness - Cowen
July 28, 2022 12:35 PM EDTCowen analyst Ken Cacciatore reiterated an Outperform rating and $35.00 price target on Bausch & Lomb Corp. (NYSE: BLCO) saying the Xifaxan loss doesn't impact the company although it likely traps the 90% ownership of BLCO by Bausch Health Companies Inc. (NYSE:... More
Evercore ISI on Bausch & Lomb Corp. (BLCO) Following Parent's Xifaxan Ruling
July 28, 2022 11:30 AM EDTEvercore ISI analyst Vijay Kumar reiterated an Outperform rating and $21.00 price target on Bausch & Lomb Corp. (NYSE: BLCO).
The analyst comments "For parent BHC to distribute the remaining ~80% of BLCO shares to holders, there are 2 datapoints that matter. First, there is a... More
